Peer Review reports
From: Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
| Original Submission | ||
|---|---|---|
| 25 Feb 2021 | Submitted | Original manuscript |
| 19 Mar 2021 | Reviewed | Reviewer Report |
| 1 Apr 2021 | Reviewed | Reviewer Report - Charles H C Halsey |
| 21 Apr 2021 | Author responded | Author comments - Margaret L. Musser |
| Resubmission - Version 2 | ||
| 21 Apr 2021 | Submitted | Manuscript version 2 |
| 23 Apr 2021 | Reviewed | Reviewer Report |
| 5 May 2021 | Reviewed | Reviewer Report - Charles H C Halsey |
| 16 May 2021 | Author responded | Author comments - Margaret L. Musser |
| Resubmission - Version 3 | ||
| 16 May 2021 | Submitted | Manuscript version 3 |
| 25 May 2021 | Reviewed | Reviewer Report |
| 27 May 2021 | Author responded | Author comments - Margaret L. Musser |
| Resubmission - Version 4 | ||
| 27 May 2021 | Submitted | Manuscript version 4 |
| 21 Jun 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 20 Jul 2021 | Editorially accepted | |
| 11 Aug 2021 | Article published | 10.1186/s12917-021-02978-8 |
You can find further information about peer review here.